Adicet reveals Phase 1 data for lupus therapy; Arcus’ ‘best-in-class’ kidney cancer drug

Plus, news about AbbVie, BlueRock Therapeutics, MaaT Pharma, Valneva, Jade Biosciences, Affinia Therapeutics, DBV Technologies, Pharming Group and Gemma Bio: 📈 Adicet Bio shares lupus data, initiates stock sale: The company’s cell therapy candidate, called ...